<DOC>
	<DOCNO>NCT03072485</DOCNO>
	<brief_summary>This phase 1 study healthy adult volunteer examine effect 3 FDA approve medication skin age applied topical form . This open label , placebo control study .</brief_summary>
	<brief_title>Phase 1 Study Effects Combining Topical FDA-approved Drugs Age-related Pathways Skin Healthy Volunteers</brief_title>
	<detailed_description>The primary endpoint study profile difference transcript level age-associated gene lamin-A , insulin like growth factor ( IGF ) NFKB pathways well noncoding RNAs topical agent-exposed arm skin versus placebo expose arm skin healthy volunteer . The secondary endpoint include ( 1 ) difference skin wrinkle use 4 point Likert scale wrinkle severity placebo topical agent expose arm skin 4 week usage ; ( 2 ) type severity adverse event , systemic skin localize exposure topical agent placebo vehicle cream .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Age great equal 55 year 2 . Female 3 . All 4 grandparent European descent 4 . Fitzpatrick Skin type 13 ( fair skin type ) 5 . Presence moderate severe fine wrinkling arm skin 6 . Presence moderate severe dyspigmentation arm skin 7 . Normal overweight body mass index 1 . History laser treatment chemical peel arm 2 . History topical antiaging product ( include retinol , tretinoin , tazarotene , azelaic acid , hydroquinone ) skin within 6 week start study 3 . History surgical procedure arm skin area include removal benign malignant skin cancer area topical study agent application 4 . Current skin condition area arm include seborrheic keratosis , rosacea , eczema may obscure study assessment 5 . History abnormal scar 6 . Uncontrolled medical problem include concurrent infection malignancy time enrollment 7 . Unable provide sign write informed consent 8 . Unable comply studyrelated procedure include keep study diary , application topical study agent , avoidance direct sun exposure &gt; 5 minute per day ultraviolet tan bed usage 9 . Not willing provide two small skin biopsy end study 10 . Known allergy sirolimus , diclofenac metformin . 11 . Known immunosuppression include organ transplant , HIV , autoimmune disease , chronic leukemia lymphoma 12 . Fasting blood sugar upper limit normal Stanford laboratory 13 . Diarrhea 14 . Use great one alcoholic beverage per day 15 . Stress surgery trauma within 2 week enrollment 16 . Liver disease hepatitis B C 17 . Planning embark dieting , caloric restriction new exercise regimen study lose weight . 18 . Unable refrain use topical agent arm besides study agent provide duration study . 19 . Hematocrit , hemoglobin , platelet , white blood cell count , serum Na , K , Cr , aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) great lesser 1.5 time limit normal . 20 . History heart failure , coronary artery disease , include angina , coronary artery bypass graft , pacemaker stent placement 21 . History bleed ulcer gastrointestinal tract 22 . History diabetes mellitus 23 . Current use blood thinner ( include heparin , warfarin aspirin ) 24 . Current use strong cytochrome P 450 ( CYP ) 3A4 inhibitor and/or Pgp ( example include ketoconazole , voriconazole , itraconazole , erythromycin , clarithromycin ) strong inducer CYP3A4 and/or Pgp ( example include rifampin rifabutin ) 25 . Abnormal lipid panel define upper limit normal Stanford laboratory</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>age</keyword>
</DOC>